BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32127392)

  • 1. Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Piano MA; Brunello A; Cappellesso R; Del Bianco P; Mattiolo A; Fritegotto C; Montini B; Zamuner C; Del Fiore P; Rastrelli M; Sommariva A; De Salvo GL; Montesco MC; Rossi CR; Zagonel V; Calabrò ML
    Clin Cancer Res; 2020 Jun; 26(12):2921-2931. PubMed ID: 32127392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.
    Thway K; Robertson D; Jones RL; Selfe J; Shipley J; Fisher C; Isacke CM
    Br J Cancer; 2016 Aug; 115(4):473-9. PubMed ID: 27434038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the alterations of the G1-S checkpoint in localized leiomyosarcoma of the peripheral soft tissue.
    Panelos J; Beltrami G; Scoccianti G; Capanna R; Paglierani M; Pepi M; Massi D; Franchi A
    Ann Surg Oncol; 2011 Feb; 18(2):566-71. PubMed ID: 20680693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
    Tian W; Wang G; Yang J; Pan Y; Ma Y
    Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D; Beltrami G; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
    West RB
    Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
    Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
    Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer.
    Kujawa KA; Zembala-Nożyńska E; Cortez AJ; Kujawa T; Kupryjańczyk J; Lisowska KM
    Cells; 2020 Jan; 9(1):. PubMed ID: 31936272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
    Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
    Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
    J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors.
    Robin YM; Penel N; Pérot G; Neuville A; Vélasco V; Ranchère-Vince D; Terrier P; Coindre JM
    Mod Pathol; 2013 Apr; 26(4):502-10. PubMed ID: 23174934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleomorphic Sarcomas: The State of the Art.
    Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
    Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
    Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients.
    Taubert H; Heidenreich C; Holzhausen HJ; Schulz A; Bache M; Kappler M; Eckert AW; Würl P; Melcher I; Hauptmann K; Hauptmann S; Schaser KD
    BMC Cancer; 2010 Feb; 10():65. PubMed ID: 20181247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of macrophage infiltration in leiomyosarcomas.
    Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
    Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.